Payward Plans Onchain Perpetual Futures for U.S. Clients

Payward, the parent company of Kraken, announced plans to offer onchain perpetual futures to clients in the U.S., starting with Hyperliquid’s HIP-3 markets. This move, pending regulatory approval, aims to enhance trading options for U.S. clients and reflects a strategic expansion into the evolving derivatives market. The news was surfaced by CryptoTwitter commentator WuBlockchain.

The Latest

The announcement from Payward comes amid mixed signals in the broader crypto market, where major assets are experiencing varying momentum. By leveraging Hyperliquid’s public blockchain for trading, Payward aims to provide U.S. clients with innovative onchain perpetual futures. The futures will be managed by Bitnomial for deployment, clearing, and settlement, while NinjaTrader Clearing will oversee client accounts. This strategic move could attract more sophisticated traders seeking to capitalize on futures trading.

Market Pulse

As of now, the overall market environment remains uncertain, with no significant price data available for Kraken or Payward. The potential introduction of onchain perpetual futures could signal a shift towards more innovative trading solutions, positioning Payward to compete effectively in the evolving crypto landscape. Traders will be keenly watching how regulatory bodies react to this initiative and whether it will set a precedent for other exchanges.

Payward, as Kraken’s parent company, operates in the cryptocurrency exchange space, providing a platform for trading various digital assets. Its jurisdiction lies within the U.S. regulatory framework, which governs the offering of financial products like futures to ensure compliance and protect investors.

What Traders Are Watching Next

Traders are observing the regulatory landscape closely as Payward’s futures offering awaits approval. The potential for increased competition in the futures market could lead to more attractive trading conditions and innovative products. Watch for developments regarding regulatory approvals and any shifts in market dynamics that may arise from this move.

This article is for informational purposes only and does not constitute financial advice.